نتائج البحث 91-100 من 6591 لعملية البحث عن Chronic Lymphocytic Leukemia
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
... Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL). Jacksonville, Fla. The purpose of this study is to assess the safety and tolerability ...
... Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) ... Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II trial studies how well ...
... chronic lymphocytic leukemia (CLL). A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma. Rochester, Minn ...
... chronic lymphocytic leukemia (CLL). A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers. Rochester, Minn., Scottsdale/Phoenix, Ariz ...
This study evaluates CLR 131 in patients with select B-cell malignancies (multiple myeloma( MM), indolent chronic lymphocytic leukemia (CLL)/small lymphocytic ...
... Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) cancer, as well as learn more about the side effects of this drug combination ...
... Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL). Jacksonville, Fla. The purpose of this study is to determine the optimal biologic dose ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.